![Erik Emerson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Emerson
Chief Executive Officer at
GLUCOTRACK, INC.
Net worth: 256 211 $ as of 2026-06-29
Profile
Erik Emerson was the founder of Symplmed Pharmaceuticals LLC, founded in 2013, serving as President & Chief Executive Officer from 2013 to 2018.
Current jobs include Chief Executive Officer & Director at GlucoTrack, Inc. starting in 2026, and Chief Executive & Director at Lokahi Therapeutics, Inc. starting in 2025.
Former jobs include Director at Adhera Therapeutics, Inc. in 2019; Marketing Director at Gilead Sciences, Inc. from 2007 to 2010; Senior Director-Commercial Development at XOMA Royalty Corp.
from 2010 to 2013; President & Director at Apimeds Pharmaceuticals US, Inc. from 2025 to 2026; Chief Commercial Officer at Mezzion Pharmaceuticals, Inc. from 2017 to 2020; and Chief Commercial Officer at Odyssey Health, Inc. from 2022 to 2023.
Education includes undergraduate studies at the University of Oregon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GLUCOTRACK INC 9.45% | 2026-07-16 | 591,570 ( 9.45% ) | 188 711 $ | 2026-06-29 |
0.5% | 2025-10-14 | 75,000 ( 0.5% ) | 67 500 $ | 2026-06-29 |
Erik Emerson active positions
| Companies | Position | Start |
|---|---|---|
| GLUCOTRACK, INC. | Chief Executive Officer | 2026-07-13 |
Former positions of Erik Emerson
| Companies | Position | End |
|---|---|---|
| ODYSSEY HEALTH, INC. | Corporate Officer/Principal | 2023-09-30 |
Mezzion Pharmaceuticals, Inc.
 Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Corporate Officer/Principal | 2019-12-31 |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 2019-12-18 |
Symplmed Pharmaceuticals LLC
 Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 2018-04-30 |
Training of Erik Emerson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
GlucoTrack, Inc.
 GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Odyssey Health, Inc.
 Odyssey Health, Inc. Medical SpecialtiesHealth Technology Develops heart monitoring and screening devices | Health Technology |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Symplmed Pharmaceuticals LLC
Symplmed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mezzion Pharmaceuticals, Inc.
Mezzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
- Stock Market
- Insiders
- Erik Emerson
